![Roger Dansey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Dansey
Direktör/Styrelseledamot på
INOVIO PHARMACEUTICALS, INC.
Förmögenhet: 66 022 $ per 2026-06-30
Profil
Roger D.
Dansey is currently an Independent Director at Inovio Pharmaceuticals, Inc. since 2021, Director at Inovio, Inc., Independent Director at Bicycle Therapeutics Plc starting in 2025, Director at Ottimo Pharma Ltd., Independent Director at Nurix Therapeutics, Inc. starting in 2025, and Director at Shasqi, Inc. Former roles include Independent Director at Kronos Bio, Inc. from 2023 to 2025, Vice President-Oncology Clinical Research at Gilead Sciences, Inc. from 2013 to 2014, Senior Vice President-Clinical Oncology Research at Merck & Co., Inc. from 2015 to 2018, Chief Executive & Medical Officer at Seagen, Inc. in 2022, SVP & Head-Therapeutic Area at Merck Research Laboratories Massachusetts LLC from 2015 to 2018, and Chief Development & Oncology Officer at Pfizer Inc. from 2024 to 2025.
Education includes a doctorate from the University of the Witwatersrand.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-13 | 13 258 ( 0,03 % ) | 56 214 $ | 2026-06-30 | |
| 2026-05-20 | 8 916 ( 0,01 % ) | 9 808 $ | 2026-06-30 | |
| 2026-05-15 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Roger Dansey
| Företag | Position | Start |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2021-05-13 |
| BICYCLE THERAPEUTICS PLC | Direktör/Styrelseledamot | 2025-09-08 |
| NURIX THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-11-10 |
Inovio, Inc.
 Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Direktör/Styrelseledamot | - |
Ultrahuman Eight Ltd.
 Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Direktör/Styrelseledamot | - |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Roger Dansey
| Företag | Position | Slut |
|---|---|---|
| KRONOS BIO, INC. | Direktör/Styrelseledamot | 2025-06-20 |
| PFIZER INC. | Företagsledare/Principal | 2025-02-05 |
| SEAGEN INC. | Verkställande Direktör | 2022-11-09 |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Roger Danseys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Inovio, Inc.
Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Technology Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ultrahuman Eight Ltd.
Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Health Technology |
